Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-FPTRP is a **fluorine-18 labeled tryptophan analog** developed as a positron emission tomography (PET) radiotracer for tumor imaging. It is a synthetic amino acid derivative, specifically 2-(3-fluoropropyl)-DL-tryptophan, designed for efficient tumor imaging. The compound acts as a substrate for amino acid transporters, primarily entering cells through **large neutral amino acid transporters (LAT)**. In vitro and in vivo studies show that it accumulates in tumor tissue, providing high tumor/background ratios in small animal PET imaging, making it potentially useful for the noninvasive imaging of tumors, especially in oncology research and diagnostics[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(3-fluoropropyl)-DL-tryptophan.